Motley Fool Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2M | Buy |
|
|||||
|
2025
Q1 | $24.7M | Buy |
|
|||||
|
2024
Q4 | $22.7M | Sell |
|
|||||
|
2024
Q3 | $29.8M | Sell |
|
|||||
|
2024
Q2 | $36.7M | Sell |
|
|||||
|
2024
Q1 | $40.1M | Sell |
|
|||||
|
2023
Q4 | $45.4M | Sell |
|
|||||
|
2023
Q3 | $43.3M | Buy |
|
|||||
|
2023
Q2 | $28.6M | Sell |
|
|||||
|
2023
Q1 | $32.8M | Sell |
|
|||||
|
2022
Q4 | $35M | Sell |
|
|||||
|
2022
Q3 | $29.1M | Sell |
|
|||||
|
2022
Q2 | $28.9M | Sell |
|
|||||
|
2022
Q1 | $27.5M | Buy |
|
|||||
|
2021
Q4 | $20.2M | Sell |
|
|||||
|
2021
Q3 | $18.1M | Sell |
|
|||||
|
2021
Q2 | $20.1M | Sell |
|
|||||
|
2021
Q1 | $18.4M | Sell |
|
|||||
|
2020
Q4 | $21.6M | Buy |
|
|||||
|
2020
Q3 | $18.6M | Buy |
|
|||||
|
2020
Q2 | $30M | Sell |
|
|||||
|
2020
Q1 | $21.2M | Sell |
|
|||||
|
2019
Q4 | $22.3M | Buy |
|